New Jersey residents will have access to the newest clinical trials and medical breakthroughs as a result of an innovative consortium between Rutgers University, Princeton University and the New Jersey Institute of Technology. To read more.
Recent Posts
- Bioengineered Blood Vessels Show Promise in Trauma Care.
- New NJACTS Publication
- Study Finds Transfusing More Blood Reduces Risk of Death at Six Months in Heart-Attack Patients with Anemia.
- New NJACTS Publication
- Princeton researchers awarded NJ ACTS grant to study dendritic plasticity in neuropsychiatric disorders.
Categories
- Community (2,129)
- Covid (981)
- CTO Events (6)
- News (2,716)
- Pilots (21)